CDH1 and synovial sarcoma: In previous research, several researchers thought that miR-9 can promote the migration and invasion of SS cells by targeting E-cadherin (also known as CDH1), which involved a process, namely, the epithelial–mesenchymal transition (EMT) (Xu et al., 2019).